ProAssurance Corporation (PRA)
Jun 26, 2026 - PRA was delisted (reason: acquired by The Doctors Company)
25.00
0.00 (0.00%)
Inactive · Last trade price on Jun 25, 2026
ProAssurance Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 921.47 | 934.24 | 968.25 | 977.4 | 1,030 | 971.67 |
Total Interest & Dividend Income | 159.52 | 156.5 | 144.54 | 128.42 | 95.97 | 70.52 |
Gain (Loss) on Sale of Investments | -7.22 | -5.49 | 1.9 | 13.83 | -33.16 | 24.31 |
Other Revenue | 21.67 | 23.66 | 28.98 | 17.57 | 14.29 | 57.91 |
| 1,095 | 1,109 | 1,144 | 1,137 | 1,107 | 1,124 | |
Revenue Growth | -3.74% | -3.04% | 0.57% | 2.76% | -1.58% | 28.51% |
Policy Benefits | 649.65 | 665.42 | 739.44 | 800.49 | 776.76 | 752.25 |
Policy Acquisition & Underwriting Costs | 130.53 | 131.32 | 135.43 | 134.81 | 133.18 | 110.61 |
Selling, General & Administrative | 178.51 | 182.75 | 183.59 | 165.93 | 172.3 | 157.64 |
Other Operating Expenses | 8.2 | 6.87 | 4.44 | 6.23 | 6.67 | 10.05 |
Total Operating Expenses | 966.89 | 986.36 | 1,063 | 1,107 | 1,089 | 1,031 |
Operating Income | 128.55 | 122.55 | 80.78 | 29.74 | 17.78 | 93.87 |
Interest Expense | -20.77 | -20.84 | -22.34 | -23.15 | -20.37 | -19.72 |
Currency Exchange Gain (Loss) | -4.65 | -10.88 | 6.73 | - | - | - |
EBT Excluding Unusual Items | 103.14 | 90.83 | 65.16 | 6.59 | -2.6 | 74.15 |
Merger & Restructuring Charges | -10.72 | -16.35 | -0.32 | - | -1.86 | - |
Impairment of Goodwill | - | - | - | -44.11 | - | - |
Other Unusual Items | - | - | - | - | - | 74.41 |
Pretax Income | 90.21 | 74.48 | 64.84 | -37.52 | -4.46 | 148.55 |
Income Tax Expense | 25.01 | 23.57 | 12.1 | 1.08 | -4.05 | 4.43 |
Net Income | 65.2 | 50.92 | 52.74 | -38.6 | -0.4 | 144.12 |
Net Income to Common | 65.2 | 50.92 | 52.74 | -38.6 | -0.4 | 144.12 |
Net Income Growth | 54.15% | -3.47% | - | - | - | - |
Shares Outstanding (Basic) | 51 | 51 | 51 | 53 | 54 | 54 |
Shares Outstanding (Diluted) | 52 | 52 | 51 | 53 | 54 | 54 |
Shares Change | 0.82% | 0.79% | -2.88% | -2.50% | 0.15% | 0.28% |
EPS (Basic) | 1.27 | 0.99 | 1.03 | -0.73 | -0.01 | 2.67 |
EPS (Diluted) | 1.26 | 0.99 | 1.03 | -0.73 | -0.01 | 2.67 |
EPS Growth | 52.08% | -3.88% | - | - | - | - |
Free Cash Flow | -38.8 | -29.22 | -19.73 | -54.68 | -34.19 | 70.13 |
Free Cash Flow Per Share | -0.75 | -0.56 | -0.39 | -1.04 | -0.63 | 1.30 |
Dividend Per Share | - | - | - | 0.050 | 0.200 | 0.200 |
Dividend Growth | - | - | - | -75.00% | 0% | -56.52% |
Operating Margin | 11.73% | 11.05% | 7.06% | 2.61% | 1.61% | 8.35% |
Profit Margin | 5.95% | 4.59% | 4.61% | -3.40% | -0.04% | 12.82% |
Free Cash Flow Margin | -3.54% | -2.63% | -1.73% | -4.81% | -3.09% | 6.24% |
EBITDA | 141.33 | 136.24 | 98.53 | 55.76 | 55.84 | 131.11 |
EBITDA Margin | 12.90% | 12.29% | 8.62% | 4.90% | 5.05% | 11.66% |
D&A For EBITDA | 12.78 | 13.69 | 17.75 | 26.02 | 38.06 | 37.25 |
EBIT | 128.55 | 122.55 | 80.78 | 29.74 | 17.78 | 93.87 |
EBIT Margin | 11.73% | 11.05% | 7.06% | 2.61% | 1.61% | 8.35% |
Effective Tax Rate | 27.73% | 31.64% | 18.66% | - | - | 2.98% |
Revenue as Reported | 1,089 | 1,098 | 1,150 | 1,137 | 1,107 | 1,124 |